Bridgepoint Group plc
("Bridgepoint" or the "Company")
New issue in connection with Bridgepoint's Long Term Incentive Plan
Bridgepoint announces that it intends to issue 687,382 ordinary shares of £0.00005 each ("New Ordinary Shares") to satisfy vesting awards under Bridgepoint's Long Term Incentive Plan. The New Ordinary Shares will rank pari passu with existing ordinary shares in issue.
An application has been made for the admission of the New Ordinary Shares to listing on the premium listing segment of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's Main Market for listed securities.
Admission is expected to occur on 28 March 2024.
In conformity with the Financial Conduct Authority's Disclosure and Transparency Rules, Bridgepoint announces that its total issued share capital following the issue of the New Ordinary Shares will comprise:
|
· |
794,346,172 ordinary shares of £0.00005 each with voting rights; and |
|
· |
500 deferred shares of £81 each, 1 deferred share of £1, and 1 deferred share of £0.01, each with no voting rights. |
Bridgepoint holds no shares in treasury. Following the issue of the New Ordinary Shares the total number of voting rights in the Company will therefore be 794,346,172, and this figure may be used by shareholders at such time as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Bridgepoint under the Disclosure Guidance and Transparency Rules.
ENQUIRIES:
Bridgepoint
|
Analysts and investors Adam Key +44 7833 748010 |
Media Christian Jones / James Murray christian.jones@bridgepoint.eu james.murray@bridgepoint.eu +44 20 7034 3500 |
FGS Global (Public Relations Adviser to Bridgepoint)
Charles O'Brien / +44 20 7251 3801 / +44 7825 043 656
Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233
bridgepoint@fgsglobal.com
Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472